Amarin Corp Plc (AMRN)

[ralphey]

UNfortunately that is not possible . This would require a competent, functioning board and management . They are clueless as to how to advance the sales of this block buster medication.

THink about this. MOve the clock back say 5-10 years.

You walk into PFIZER / GSK / Merck and you say to them. I have a new medication that will reduce by 25% the number one killer of adults over 40 and it has hardly any side effects.

THis is a no brainer - this medication should get instantaneous traction and be worth billions.

And yet EUNUCHA ( formerly AMRN) has totally failed to capitalize on this - it is indeed rather unbelievable. Like I have said many times, this company will be taught in business schools as the PRIME Example of how incompetent management can totally destroy a wonderful product